Paper475368
In vitro susceptibility of Ureaplasma urealyticum to rosaramicin.
Smith TF. Antimicrob Agents Chemother, 1979. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. In vitro susceptibility of Ureaplasma urealyticum to rosaramicin. Papers, record 475368. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/475368
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Leucomycins | Major topic |
| Ureaplasma | Major topic |
| Minocycline | |
| Tetracycline |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 63,748 | Differential response of chlamydial and ureaplasma-associated urethritis to sulphafurazole (sulfisoxazole) and aminocyclitols. | Lancet | 1976 | https://conductscience.org/library/papers/63748 | PubMed |
| 2 | 105,799 | Research for new antibiotics in the treatment of gonorrhea and nonspecific urethritis. | Can Med Assoc J | 1978 | https://conductscience.org/library/papers/105799 | PubMed |
| 3 | 409,345 | In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/409345 | PubMed |
| 4 | 730,828 | Serological typing of Ureaplasma urealyticum isolates from urethritis patients by an agar growth inhibition method. | J Clin Microbiol | 1978 | https://conductscience.org/library/papers/730828 | PubMed |
| 5 | 708,027 | In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/708027 | PubMed |
| 6 | 644,417 | Etiology and treatment of nongonococcal urethritis. | Sex Transm Dis | 1978 | https://conductscience.org/library/papers/644417 | PubMed |
| 7 | 918,250 | Human intra-urethral inoculation of ureplasmas. | Q J Med | 1977 | https://conductscience.org/library/papers/918250 | PubMed |
| 8 | 853,244 | Differences in the growth requirements of some strains of Ureaplasma urealyticum of human origin. | J Infect Dis | 1977 | https://conductscience.org/library/papers/853244 | PubMed |
| 9 | 848,933 | Simple, direct broth-disk method for antibiotic susceptibility testing of Ureaplasma urealyticum. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/848933 | PubMed |
| 10 | 984,752 | In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984752 | PubMed |
| 11 | 984,811 | Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984811 | PubMed |
| 12 | 4,313,312 | Susceptibility of genital mycoplasmas to antimicrobial agents. | Appl Microbiol | 1970 | https://conductscience.org/library/papers/4313312 | PubMed |
| 13 | 4,212,201 | Nongonococcal urethritis. A venereal disease as prevalent as epidemic gonorrhea. | Arch Intern Med | 1974 | https://conductscience.org/library/papers/4212201 | PubMed |
| 14 | 163,932 | Are chlamydial infections the most prevalent venereal disease? | JAMA | 1975 | https://conductscience.org/library/papers/163932 | PubMed |
| 15 | 4,840,436 | Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4840436 | PubMed |
| 16 | 4,925,243 | Urease color test medium U-9 for the detection and identification of "T" mycoplasms in clinical material. | Appl Microbiol | 1970 | https://conductscience.org/library/papers/4925243 | PubMed |
| 17 | 1,267,432 | Rosamicin: in vitro activity against anaerobes and comparison with erythromycin. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1267432 | PubMed |
| 18 | 5,929,693 | T-strain Mycoplasma. Selective inhibition by erythromycin in vitro. | Br J Vener Dis | 1966 | https://conductscience.org/library/papers/5929693 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,283,415 | Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7283415 | PubMed |
| 3,920,959 | Activities of new quinoline derivatives against genital pathogens. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3920959 | PubMed |
| 3,536,500 | Antimicrobial chemotherapy of chlamydial infection: where next? | Eur J Clin Microbiol | 1986 | https://conductscience.org/library/papers/3536500 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/475368
GET https://conductscience.org/api/papers/v1/475368/authors